Vulnerability · CVE-2019-1129
Microsoft Windows AppX Deployment Service (AppXSVC) Privilege Escalation Vulnerability
Published Jul 15, 2019 · catalog updated Jun 16, 2026 · Microsoft Windows
Patch now
CVE-2019-1129 is in the CISA known-exploited catalog, due Apr 5, 2022. Confirm Microsoft Windows against the vendor advisory and apply that fix. The CVSS score does not change the priority.
Gaps on this record
- No version range is stored. A customer cannot check an installed version against this record.
- Severity
- High7.8
- Known exploitation
- CISA KEV and VulnCheck KEV
- EPSS
- 1.78%
- Remediation
- Remediation guidance
- Affected products
- cpe microsoft/windows 10 1703 · cpe microsoft/windows 10 1709 · cpe microsoft/windows 10 1803 · vendor Microsoft Windows
An elevation of privilege vulnerability exists when Windows AppX Deployment Service (AppXSVC) improperly handles hard links, aka 'Windows Elevation of Privilege Vulnerability'. This CVE ID is unique from CVE-2019-1130.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- cpe microsoft/windows 10 1703version unspecified
- cpe microsoft/windows 10 1709version unspecified
- cpe microsoft/windows 10 1803version unspecified
- vendor Microsoft Windowsversion unspecified
How to fix CVE-2019-1129
Recommended remediation
Apply updates per vendor instructions. CISA due date Apr 5, 2022.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
CVE-2019-1129 is in the CISA known-exploited catalog, due Apr 5, 2022. Confirm Microsoft Windows against the vendor advisory and apply that fix. The CVSS score does not change the priority.
Which versions are affected?
Affected version ranges are not on this record. Apply updates per vendor instructions.
What should an analyst verify?
CWE-59: Link Following. EPSS 1.78%. The CISA KEV listing is the exploitation evidence. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Technology hubs
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Jul 15, 2019 · Catalog
Detected
An elevation of privilege vulnerability exists when Windows AppX Deployment Service (AppXSVC) improperly handles hard links, aka 'Windows Elevation of Privilege Vulnerability'. This CVE ID is unique from CVE-2019-1130.
Mar 15, 2022 · CISA KEV
Known exploited
Apply updates per vendor instructions.
Apr 5, 2022 · CISA KEV
Remediation due
Apply updates per vendor instructions.
Jun 16, 2026 · Catalog
Updated
An elevation of privilege vulnerability exists when Windows AppX Deployment Service (AppXSVC) improperly handles hard links, aka 'Windows Elevation of Privilege Vulnerability'. This CVE ID is unique from CVE-2019-1130.
Sources
- CISA KEVConfirmed exploitationCVE-2019-1129
A privilege escalation vulnerability exists when Windows AppXSVC improperly handles hard links. An attacker who successfully exploited this vulnerability could run processes in an elevated context.
cisa.gov - CVE.orgVulnerability recordCVE-2019-1129
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2019-1129
30-day exploitation probability 1.8%
first.org - NIST NVDVulnerability recordCVE-2019-1129
An elevation of privilege vulnerability exists when Windows AppX Deployment Service (AppXSVC) improperly handles hard links, aka 'Windows Elevation of Privilege Vulnerability'. This CVE ID is unique from CVE-2019-1130.
nvd.nist.gov - VulnCheck KEVConfirmed exploitationCVE-2019-1129
A privilege escalation vulnerability exists when Windows AppXSVC improperly handles hard links. An attacker who successfully exploited this vulnerability could run processes in an elevated context.
vulncheck.com
References
Freshness
Last verified in this catalog Oct 17, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.